Trademark: 79312182
Status Date
Tuesday, March 29, 2022
Registration Number
6681657
Registration Date
Tuesday, March 29, 2022
Filing Date
Wednesday, January 20, 2021
Published for Opposition
Tuesday, January 11, 2022
5 Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; diagnostic reagents for medical use
42 Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable database; conducting clinical trials for others; pharmaceutical and biological product development and research services for third parties; conducting clinical research for others; evaluation of the efficacy of pharmaceutical products; clinical product development services
Sep 12, 2022
Final Decision Transaction Processed By Ib
Aug 23, 2022
Final Disposition Notice Sent To Ib
Aug 23, 2022
Final Disposition Processed
Jun 29, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 8, 2022
New Representative At Ib Received
Mar 29, 2022
Registered-Principal Register
Jan 11, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 11, 2022
Published For Opposition
Jan 10, 2022
Notification Processed By Ib
Dec 22, 2021
Notification Of Possible Opposition Sent To Ib
Dec 22, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 22, 2021
Notification Of Notice Of Publication E-Mailed
Dec 9, 2021
Law Office Publication Review Completed
Dec 9, 2021
Assigned To Lie
Dec 8, 2021
Approved For Pub - Principal Register
Dec 6, 2021
Teas/Email Correspondence Entered
Dec 6, 2021
Correspondence Received In Law Office
Dec 6, 2021
Teas Response To Office Action Received
Sep 11, 2021
Refusal Processed By Ib
Aug 25, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Aug 25, 2021
Refusal Processed By Mpu
Aug 7, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Aug 6, 2021
Non-Final Action Written
Aug 3, 2021
Assigned To Examiner
Jun 12, 2021
Application Filing Receipt Mailed
Jun 8, 2021
New Application Office Supplied Data Entered In Tram
Jun 7, 2021
Limitation From Original Application Entered
Jun 3, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
